1- https://doi.org/10.1016/j.annonc.2025.12.013
A tale of two trials: TAILORx and PlanB. Letter to the Editor regarding 'Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer' by Chen et al.
Abstract
Translate Article 
Take Notes
Translate Article Take Notes A tale of two trials: TAILORx and PlanB. Letter to the Editor regarding 'Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer' by Chen et al.
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.
